Patrick Paul McIlvenny - 18 Mar 2026 Form 3 Insider Report for Autolus Therapeutics plc (AUTL)

Role
SVP Finance
Signature
/s/ Patrick McIlvenny
Issuer symbol
AUTL
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 19:55:01 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McIlvenny Patrick Paul SVP Finance C/O AUTOLUS THERAPEUTICS PLC, THE MEDIAWORKS, 191 WOOD LN, WHITE CITY, LONDON, UNITED KINGDOM /s/ Patrick McIlvenny 18 Mar 2026 0002121503

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AUTL Share Option (right to buy) 18 Mar 2026 American Depositary Shares 150,000 $1.49 Direct F1
holding AUTL Share Option (right to buy) 18 Mar 2026 American Depositary Shares 148,000 $1.62 Direct F2
holding AUTL Restricted Share Units 18 Mar 2026 American Depositary Shares 33,000 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests 25% on October 8, 2026 and the remainder vests in 36 equal monthly installments thereafter.
F2 This option vests 25% on March 4, 2027 and the remainder vests in 36 equal monthly installments thereafter.
F3 The RSUs vest in four equal annual installments commencing on March 4, 2027.
F4 Each RSU represents a contingent right to receive one Issuer American Depositary Share.